Fernwood Investment Management LLC Sells 346 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Fernwood Investment Management LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 8.2% in the 4th quarter, Holdings Channel reports. The fund owned 3,873 shares of the financial services provider’s stock after selling 346 shares during the quarter. Fernwood Investment Management LLC’s holdings in iShares Biotechnology ETF were worth $526,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Lake Street Financial LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter worth about $799,000. Brookstone Capital Management boosted its position in iShares Biotechnology ETF by 153.4% during the third quarter. Brookstone Capital Management now owns 6,484 shares of the financial services provider’s stock valued at $763,000 after purchasing an additional 3,925 shares during the last quarter. ST Germain D J Co. Inc. boosted its position in iShares Biotechnology ETF by 14.1% during the third quarter. ST Germain D J Co. Inc. now owns 1,335 shares of the financial services provider’s stock valued at $163,000 after purchasing an additional 165 shares during the last quarter. FAS Wealth Partners Inc. boosted its position in iShares Biotechnology ETF by 3.1% during the third quarter. FAS Wealth Partners Inc. now owns 25,456 shares of the financial services provider’s stock valued at $3,113,000 after purchasing an additional 755 shares during the last quarter. Finally, Sheets Smith Wealth Management acquired a new position in iShares Biotechnology ETF during the third quarter valued at approximately $101,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB traded up $1.88 during trading hours on Monday, hitting $128.37. 1,761,053 shares of the company traded hands, compared to its average volume of 1,795,517. The business’s 50-day moving average is $134.12 and its 200-day moving average is $129.88. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.39%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.